Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/25/2010US20100075969 Angiogenesis
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/25/2010US20100075966 Substituted Dihydroimidazoles and their Use in the Treatment of Tumors
03/25/2010US20100075965 Pi3 kinase inhibitors and methods of their use
03/25/2010US20100075964 Imidazole based lxr modulators
03/25/2010US20100075963 Pharmaceutically Active Benzensulphonyl-Indols
03/25/2010US20100075962 Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient
03/25/2010US20100075961 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100075960 Benzimidazole thiophene compounds
03/25/2010US20100075959 Benzothiazole derivatives with activity as adenosine receptor ligands
03/25/2010US20100075958 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/25/2010US20100075957 Aminodihydrothiazine derivatives substituted with a cyclic group
03/25/2010US20100075956 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
03/25/2010US20100075955 Short-acting benzodiazepine salts and their polymorphic forms
03/25/2010US20100075954 Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075952 Pyrrolo-nitrogenous heterocyclic derivaties,the preparation and the pharmcetical use theeof
03/25/2010US20100075951 Heteroaryls and uses thereof
03/25/2010US20100075950 Phenylpropanone modulators of dopamine receptor
03/25/2010US20100075949 Novel pyrrolidin-2-ones
03/25/2010US20100075948 Substituted Pyrrolidine-2-Carboxamides
03/25/2010US20100075947 Methods of Using PI3K and MEK Modulators
03/25/2010US20100075946 Novel thiophene derivatives
03/25/2010US20100075945 Gram-positive carbapenem antibacterials and processes for their preparation
03/25/2010US20100075944 Novel pyridine derivatives and pyrimidine derivatives (3)
03/25/2010US20100075943 1-adamantylazetidin-2-one derivatives and drugs containing same
03/25/2010US20100075942 N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancer
03/25/2010US20100075941 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
03/25/2010US20100075940 Dendritic polyamidoamine phthalocyanine derivative
03/25/2010US20100075938 Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
03/25/2010US20100075937 Patient populations and treatment methods
03/25/2010US20100075936 Use of glucocorticoid receptor antagonists for treatment of infectious conditions
03/25/2010US20100075935 Xanthine modulators of adenosine a1 receptor
03/25/2010US20100075934 5-lipoxygenase activating protein (flap) inhibitor
03/25/2010US20100075933 Injectable compositions of vitamin d compounds
03/25/2010US20100075932 Novel salicylic anilides
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010US20100075930 Salicylic salt compositions and related method of treatment of cardiac conditions
03/25/2010US20100075929 9-aminoacyl tetracycline compounds and methods of use thereof
03/25/2010US20100075928 Cancer treatment method
03/25/2010US20100075927 Chemotherapeutic conjugates and methods of use
03/25/2010US20100075926 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
03/25/2010US20100075925 Hyperthermic Technologies And Therapeutic Uses Thereof
03/25/2010US20100075924 Dutpase inhibitors
03/25/2010US20100075923 Method of enhancing tgf-beta signalling
03/25/2010US20100075922 Heparins including at least one covalent bond with biotin or a biotin derivative, method for preparing same and use thereof
03/25/2010US20100075921 Prêparation of hyaluronic acid with desired low molecular weight as a food supplement
03/25/2010US20100075920 Small molecule stimulators of neuronal growth
03/25/2010US20100075918 Hyaluronidase inhibitors as anti-cancer agents
03/25/2010US20100075917 Thionucleosides and pharmaceutical applications
03/25/2010US20100075916 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/25/2010US20100075915 Methods for cancer therapy and stem cell modulation
03/25/2010US20100075914 Methods for treating herpes virus infections
03/25/2010US20100075913 Pharmaceutical anti-infective composition for inhalation
03/25/2010US20100075912 Novel morphine derivatives
03/25/2010US20100075901 Novel use of hiv nc protein
03/25/2010US20100075900 Use of Nutritional Compositions for Preventing Disorders
03/25/2010US20100075898 N-terminal vdac variants and uses thereof
03/25/2010US20100075894 Reducing er stress in the treatment of obesity and diabetes
03/25/2010US20100075891 Novel polynucleotides encoding polypeptides and methods using same
03/25/2010US20100074977 Methods for treating glioblastoma with herbal compositions
03/25/2010US20100074973 Thioxanthene modulators of dopamine d2 receptors
03/25/2010US20100074969 Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix
03/25/2010US20100074968 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)
03/25/2010US20100074960 High-loading, controlled-release magnesium oral dosage forms and methods of making and using same
03/25/2010US20100074959 Lipid growth factor formulations
03/25/2010US20100074958 Methods and compositions for targeting fenestrated vasculature
03/25/2010US20100074957 Intraocular formulation
03/25/2010US20100074955 Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity
03/25/2010US20100074953 Methods for intiating in situ formation of hydrogels
03/25/2010US20100074952 Tasted masked veterinary solid compositions
03/25/2010US20100074951 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
03/25/2010US20100074950 Anti-diabetic combinations
03/25/2010US20100074949 Pharmaceutical composition and administration thereof
03/25/2010US20100074948 Method of producing fast dissolving tablets
03/25/2010US20100074944 Transdermal Tobacco Alkaloid Reservoir Patch
03/25/2010US20100074943 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
03/25/2010US20100074942 Device and method for intraocular drug delivery
03/25/2010US20100074940 Linear polyesteramides from aminophenolic esters
03/25/2010US20100074939 Harmine compounds for promoting bone growth
03/25/2010US20100074938 Immobilised biological entities
03/25/2010US20100074934 Medical implants with a combination of compounds
03/25/2010US20100074931 Use of a highly emulsified silicone oil (hes) for the production of a medicament
03/25/2010US20100074927 Delivery of therapeutic compounds via microparticles or microbubbles
03/25/2010US20100074908 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
03/25/2010US20100074907 Methods for Promoting Myelination, Neuronal Survival and Oligodendrocyte Differentiation Via Administration of SP35 or TrkA Antagonists
03/25/2010US20100074898 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
03/25/2010US20100074897 Methods and Compositions related to HIF-1 alpha
03/25/2010US20100074895 Method for detecting and controlling cancer
03/25/2010US20100074891 Sclerostin and the inhibition of Wnt signaling and bone formation
03/25/2010US20100074889 4'-allene-substituted nucleoside derivatives
03/25/2010US20100074888 Animal having modification in mgat2 gene
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/25/2010US20100074886 Ccr2 antagonists for treatment of fibrosis
03/25/2010US20100074884 Inhibition of neuronal damage
03/25/2010US20100074882 Methods and compositions for preserving the viability of photoreceptor cells
03/25/2010US20100074881 Multiple nebulizer systems
03/25/2010US20100074880 Polyethylene glycol derivative
03/25/2010US20100074867 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
1 ... 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 ... 7860